Scholar Rock Stock (SRRK) Slides Over 7% on an FDA Safety Update
Scholar Rock stock dropped over 7% on Tuesday after an FDA update related to safety terms for approval of ISEMBYLD.
Scholar Rock Holding Corp (SRRK)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Siren L.L.C. Raymond Debbane | 9,575,013 | $526,625,715 | -12% | 10.66% |
| 2. | Samsara BioCapital Srini Akkaraju And Michael Dybbs | 6,897,652 | $379,370,860 | 31.16% | |
| 3. | Orbis Investment Management William B. Gray | 5,933,533 | $326,344,315 | +42% | 1.12% |
| 4. | Redmile Group Jeremy Green | 4,311,092 | $237,110,060 | -53% | 15.92% |
| 5. | Hood River Capital Management David Swank | 2,224,788 | $122,363,340 | +9% | 0.89% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $40.97 | 4,403 | $180,390.91 | 530,038 | 2025-10-07 | Filing | |
| $40.18 | 12,400 | $498,232.00 | 525,635 | 2025-10-07 | Filing | |
| $39.31 | 12,796 | $503,010.76 | 513,235 | 2025-10-07 | Filing | |
| $39.52 | 13,748 | $543,320.96 | 500,439 | 2025-10-06 | Filing | |
| $38.68 | 80,863 | $3,127,780.84 | 486,691 | 2025-10-06 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $54.88 | 15 | $823.14 | 27,856 | 2026-07-01 | Filing | |
| $54.24 | 1,470 | $79,727.66 | 27,871 | 2026-07-01 | Filing | |
| $53.53 | 1,568 | $83,939.43 | 29,341 | 2026-07-01 | Filing | |
| $54.81 | 43 | $2,357.02 | 59,511 | 2026-07-01 | Filing | |
| $54.23 | 1,155 | $62,630.68 | 59,554 | 2026-07-01 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 17,995,241 | $989,738,234 | 0.04% | |
| 2. | 9,494,084 | $522,174,620 | 0.01% | |
| 3. | 6,727,085 | $369,989,675 | 0.06% | |
| 4. | 4,767,880 | $262,233,400 | 0.01% | |
| 5. | 4,728,681 | $260,077,455 | 0.01% |
News See All
Is Scholar Rock Holding Corporation (SRRK) Better Positioned than Novo Nordisk A/S (NVO) After Recent Setbacks?
Two healthcare players, Scholar Rock Holding Corporation (NASDAQ:SRRK) and Novo Nordisk A/S (NYSE:NVO), find their near-term narratives intertwined over manufacturing compliance.
Scholar Rock Holding Corporation (NASDAQ:SRRK) Q1 2026 Earnings Call Transcript
Scholar Rock Holding Corporation (NASDAQ:SRRK) Q1 2026 Earnings Call Transcript May 7, 2026Scholar Rock Holding Corporation misses on earnings expectations.
Scholar Rock Holding Corporation (NASDAQ:SRRK) Q4 2025 Earnings Call Transcript
Scholar Rock Holding Corporation (NASDAQ:SRRK) Q4 2025 Earnings Call Transcript March 3, 2026Scholar Rock Holding Corporation beats earnings expectations.
Scholar Rock (SRRK) Soars 29% as Drug Candidate Progresses
We recently published 10 Market Movers That Made Millionaires in a Week. Scholar Rock Holding Corp. (NASDAQ:SRRK) is one of the best-performing stocks of the past trading week.
Scholar Rock Holding Corporation (NASDAQ:SRRK) Q3 2025 Earnings Call Transcript
Scholar Rock Holding Corporation (NASDAQ:SRRK) Q3 2025 Earnings Call Transcript November 14, 2025Scholar Rock Holding Corporation misses on earnings expectations.
Scholar Rock (SRRK) Climbs 24% on Drug Candidate Progress
We recently published Lackluster Market? Not for These 10 Soaring Stocks. Scholar Rock Holding Corp. (NASDAQ:SRRK) is one of the best-performing stocks on Friday.
Can Apitegromab Approval Turn Scholar Rock (SRRK) Into the Next Biotech Multibagger?
Scholar Rock Holding Corp. (NASDAQ:SRRK) is one of the best multibagger stocks to invest in right now.
15 Best Multibagger Stocks to Invest in Right Now
In this article, we will examine the 15 Best Multibagger Stocks to Invest in Right Now.
Scholar Rock (SRRK) Jumps 14% on Bargain-Hunting, Price Down 20.4% YTD
We recently published 10 Big Names With Surprising Gains. Scholar Rock Holding Corp. (NASDAQ:SRRK) is one of Wednesday’s best performers.
Hedge Fund Resource Center